Michael Schickler
General Counsel at PURPLE BIOTECH LTD
Profile
Michael Schickler is the founder of CureTech Ltd.
(founded in 1995) and holds the title of Director.
He is currently the Chief Executive Officer at FameWave Ltd., Chairman at Mindset BioPharmaceuticals Ltd., and Head of Clinical Operations & Regulatory Affairs at Purple Biotech Ltd.
He has previously worked as a Director at MediWound Ltd.
and Accellta Ltd., Vice President of Development at W World Corp., and Principal at Hoffmann-La Roche, Inc. Dr. Schickler has an undergraduate and graduate degree from Tel-Aviv University and a doctorate from the Weizmann Institute of Science.
Michael Schickler active positions
| Companies | Position | Start |
|---|---|---|
| PURPLE BIOTECH LTD | General Counsel | 2019-12-31 |
Mindset BioPharmaceuticals Ltd.
 Mindset BioPharmaceuticals Ltd. Medical/Nursing ServicesHealth Services Mindset BioPharmaceuticals Ltd. develops disease modifying therapies. It specializes in molecular neuropharmacology, behavioral science, clinical neurology, drug delivery, and biopharmaceutical development. The company was founded by Daniel G. Chain in February 1997 and is headquartered in Jerusalem, Israel. | Chairman | - |
CureTech Ltd.
 CureTech Ltd. BiotechnologyHealth Technology CureTech Ltd. operates as a biotechnology company. It develops novel and immune modulating products for the treatment and control of cancer. The company was founded by Michael Schickler in 1995 and is headquartered in Yavne, Israel. | Founder | 1995-06-26 |
FameWave Ltd.
 FameWave Ltd. Pharmaceuticals: MajorHealth Technology FameWave Ltd. is a biopharmaceutical company engaging in the development of medications for the treatment of cancer. Its product is CM-24. The company was founded on July 2, 2017 and is headquartered in Tel Aviv, Israel. | Chief Executive Officer | 2018-05-31 |
Former positions of Michael Schickler
| Companies | Position | End |
|---|---|---|
Accellta Ltd.
 Accellta Ltd. BiotechnologyHealth Technology Accellta Ltd. offers solutions for stem cell culturing. Its portfolio include pluripotent stem cell culturing, human foreskin-derived feeder cells, growth media for feeder-free culturing of hPSC, stem cell expansion in suspension, stem cell culturing as single-cells in bioreactors, stem-cell controlled differentiation, and medium formulation. The company was founded in 2012 and is headquartered in Haifa, Israel. | Director/Board Member | - |
| MEDIWOUND LTD. | Director/Board Member | - |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Corporate Officer/Principal | - |
| W WORL | Corporate Officer/Principal | - |
Training of Michael Schickler
| Tel-Aviv University | Graduate Degree |
| Weizmann Institute of Science | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| W WORL | Health Technology |
| MEDIWOUND LTD. | Health Technology |
| PURPLE BIOTECH LTD | Health Technology |
| Private companies | 5 |
|---|---|
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Health Technology |
Mindset BioPharmaceuticals Ltd.
Mindset BioPharmaceuticals Ltd. Medical/Nursing ServicesHealth Services Mindset BioPharmaceuticals Ltd. develops disease modifying therapies. It specializes in molecular neuropharmacology, behavioral science, clinical neurology, drug delivery, and biopharmaceutical development. The company was founded by Daniel G. Chain in February 1997 and is headquartered in Jerusalem, Israel. | Health Services |
CureTech Ltd.
CureTech Ltd. BiotechnologyHealth Technology CureTech Ltd. operates as a biotechnology company. It develops novel and immune modulating products for the treatment and control of cancer. The company was founded by Michael Schickler in 1995 and is headquartered in Yavne, Israel. | Health Technology |
Accellta Ltd.
Accellta Ltd. BiotechnologyHealth Technology Accellta Ltd. offers solutions for stem cell culturing. Its portfolio include pluripotent stem cell culturing, human foreskin-derived feeder cells, growth media for feeder-free culturing of hPSC, stem cell expansion in suspension, stem cell culturing as single-cells in bioreactors, stem-cell controlled differentiation, and medium formulation. The company was founded in 2012 and is headquartered in Haifa, Israel. | Health Technology |
FameWave Ltd.
FameWave Ltd. Pharmaceuticals: MajorHealth Technology FameWave Ltd. is a biopharmaceutical company engaging in the development of medications for the treatment of cancer. Its product is CM-24. The company was founded on July 2, 2017 and is headquartered in Tel Aviv, Israel. | Health Technology |
- Stock Market
- Insiders
- Michael Schickler
